Journal article 1325 views 1773 downloads
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial
The Lancet Diabetes & Endocrinology, Volume: 9, Issue: 4, Pages: 212 - 224
Swansea University Author:
Steve Bain
-
PDF | Accepted Manuscript
©2021 All rights reserved. All article content, except where otherwise noted, is licensed under a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND)
Download (1.88MB)
DOI (Published version): 10.1016/s2213-8587(21)00019-x
Abstract
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial
| Published in: | The Lancet Diabetes & Endocrinology |
|---|---|
| ISSN: | 2213-8587 2213-8595 |
| Published: |
Elsevier BV
2021
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa56262 |
| College: |
Faculty of Medicine, Health and Life Sciences |
|---|---|
| Funders: |
Novo Nordisk. |
| Issue: |
4 |
| Start Page: |
212 |
| End Page: |
224 |

